Use of haemopoietic growth factors: commentary on the ASCO/ECOG guidelines. American Society of Clinical Oncology/Eastern Co-operative Oncology Group. (Q41527318)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 1997

Language	Label	Description	Also known as
English	Use of haemopoietic growth factors: commentary on the ASCO/ECOG guidelines. American Society of Clinical Oncology/Eastern Co-operative Oncology Group.	scientific article published on March 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

Use of haemopoietic growth factors: commentary on the ASCO/ECOG guidelines. American Society of Clinical Oncology/Eastern Co-operative Oncology Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

A P Haynes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

N H Russell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

16-27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9218103%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary Results of Treatment with Filgrastim for Relapse of Leukemia and Myelodysplasia after Allogeneic Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of peripheral blood stem cell mobilization

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Haematological study of healthy volunteers 5 years after G-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Broad inter‐individual variations in circulating progenitor cell numbers induced by granulocyte colony‐stimulating factor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990003-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0268-960X(97)90003-5

1 reference

https://api.fatcat.wiki/v0/release/4lx7chpdxzgzpjtqkukqi6fjq4

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_4lx7chpdxzgzpjtqkukqi6fjq4

1 reference

https://api.fatcat.wiki/v0/release/4lx7chpdxzgzpjtqkukqi6fjq4

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/4lx7chpdxzgzpjtqkukqi6fjq4

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41527318&oldid=1801611359"